Maxcyte (MXCT) Cash from Operations (2020 - 2026)
Maxcyte (MXCT) reported Cash from Operations of 8169000.0 for Q1 2026, up 43.31% year-over-year from 5700065.8 in Q1 2025, and down 203.79% on a QoQ basis from 2689000.0 in Q4 2025.
Maxcyte (MXCT) has 7 years of Cash from Operations data on file, last reported at 8169000.0 in Q1 2026.
- Quarterly Cash from Operations rose 43.31% year-over-year to 8169000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28168000.0 (up 10.46% YoY) and the FY2025 annual result came in at 34410000.0, down 24.63% from the prior year.
- Cash from Operations retreated to 8169000.0 in Q1 2026 per MXCT's latest filing, from 2689000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 981000.0 in Q4 2023 and bottomed at 14411000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 6086400.0 (2022), against an average of 6274000.0.
- The widest annual swing landed in 2022, when Cash from Operations surged 120.94%; it then plunged 1200.04% in 2023.
- Tracing MXCT's Cash from Operations over 5 years: stood at 6086400.0 in 2022, then jumped by 116.12% to 981000.0 in 2023, then tumbled by 897.25% to 7821000.0 in 2024, then surged by 65.62% to 2689000.0 in 2025, then tumbled by 203.79% to 8169000.0 in 2026.
- Per Business Quant, the three latest MXCT Cash from Operations figures stand at 8169000.0 (Q1 2026), 2689000.0 (Q4 2025), and 7458000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | -8.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.17 Mn |
| Mar 31, 2026 | -8.17 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -7.46 Mn |
| Sep 30, 2025 | -7.46 Mn |
| Jun 30, 2025 | -9.85 Mn |
| Jun 30, 2025 | -9.85 Mn |
| Mar 31, 2025 | -14.41 Mn |
| Mar 31, 2025 | -14.41 Mn |
| Dec 31, 2024 | -7.82 Mn |
| Dec 31, 2024 | -7.82 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -4.83 Mn |
| Mar 31, 2024 | -10.56 Mn |
| Mar 31, 2024 | -10.56 Mn |
| Dec 31, 2023 | 981,000.00 |
| Dec 31, 2023 | 981,000.00 |
| Sep 30, 2023 | -8.24 Mn |
| Sep 30, 2023 | -8.24 Mn |
| Jun 30, 2023 | -10.11 Mn |
| Jun 30, 2023 | -10.11 Mn |
| Mar 31, 2023 | -4.32 Mn |
| Mar 31, 2023 | -4.32 Mn |
| Dec 31, 2022 | -6.09 Mn |
| Dec 31, 2022 | -6.09 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Jun 30, 2022 | 918,600.00 |
| Jun 30, 2022 | 918,600.00 |
| Mar 31, 2022 | -3.69 Mn |
| Mar 31, 2022 | -3.69 Mn |
| Dec 31, 2021 | -960,250.00 |
| Dec 31, 2021 | -960,250.00 |
| Sep 30, 2021 | -690,450.00 |
| Sep 30, 2021 | -690,450.00 |
| Jun 30, 2021 | -4.39 Mn |
| Jun 30, 2021 | -4.39 Mn |
| Mar 31, 2021 | -4.64 Mn |
| Mar 31, 2021 | -4.64 Mn |
| Dec 31, 2020 | -1.91 Mn |
| Dec 31, 2020 | -1.91 Mn |
| Sep 30, 2020 | -830,300.00 |
| Sep 30, 2020 | -830,300.00 |